{"id":64245,"date":"2020-03-03T15:15:57","date_gmt":"2020-03-03T07:15:57","guid":{"rendered":"http:\/\/www.namnewsnetwork.org\/?p=64245"},"modified":"2020-03-03T15:16:00","modified_gmt":"2020-03-03T07:16:00","slug":"takeda-agrees-to-divest-select-otc-and-non-core-assets-in-latin-america-to-hypera-pharma-for-825-million-usd","status":"publish","type":"post","link":"http:\/\/namnewsnetwork.org\/?p=64245","title":{"rendered":"Takeda Agrees to Divest Select OTC and Non-Core Assets in Latin America to Hypera Pharma for $825 Million USD"},"content":{"rendered":"\n<p><strong>OSAKA, Japan, March 3 (Bernama-BUSINESS WIRE) &#8212;\u00a0<\/strong>Takeda Pharmaceutical Company Limited (<a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&amp;esheet=52182092&amp;newsitemid=20200302005426&amp;lan=en-US&amp;anchor=TSE%3A4502%2FNYSE%3ATAK&amp;index=1&amp;md5=2f93649aae56c094ece5e3aa7a563cc3\">TSE:4502\/NYSE:TAK<\/a>) (\u201cTakeda\u201d) today announced that it has entered into an agreement to divest a portfolio of select non-core products exclusively in Latin America to Hypera S.A. (\u201cHypera Pharma\u201d), Brazil\u2019s largest pharmaceutical company with a leading position in branded prescriptions, consumer health and branded generics, for a total value of $825M USD.<\/p>\n\n\n\n<p>The portfolio includes over-the-counter and prescription pharmaceutical products sold in Brazil, Mexico, Argentina, Colombia, Ecuador, Panama and Peru, which are part of Takeda\u2019s Growth &amp; Emerging Markets Business Unit.<\/p>\n\n\n\n<p><a href=\"http:\/\/mrem.bernama.com\/viewsm.php?idm=36865\">http:\/\/mrem.bernama.com\/viewsm.php?idm=36865<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>OSAKA, Japan, March 3 (Bernama-BUSINESS WIRE) &#8212;\u00a0Takeda Pharmaceutical Company Limited (TSE:4502\/NYSE:TAK) (\u201cTakeda\u201d) today announced that it has entered into an agreement to divest a portfolio of select non-core products exclusively in Latin America to Hypera S.A. (\u201cHypera Pharma\u201d), Brazil\u2019s largest pharmaceutical company with a leading position in branded prescriptions, consumer health and branded generics, for [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[315],"tags":[],"_links":{"self":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts\/64245"}],"collection":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=64245"}],"version-history":[{"count":0,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts\/64245\/revisions"}],"wp:attachment":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=64245"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=64245"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=64245"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}